NCT02365597 2026-04-13
An Efficacy and Safety Study of Erdafitinib (JNJ-42756493) in Participants With Urothelial Cancer
Janssen Research & Development, LLC
Phase 2 Active not recruiting
Clinical Trials
6 trialsNCT04557449 2025-10-01
CDK4i
Pfizer
Phase 2 Active not recruiting
NCT03436485 2025-07-22
CYPIDES
Orion Corporation, Orion Pharma
Phase 1/2 Active not recruiting
NCT04676035 2023-02-09
The DDI Study Had Been Designed to Investigate the Effect of SHR3680 on the Pharmacokinetics of Midazolam, S-Warfarin and Omeprazole
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Completed
NCT03237416 2018-11-06
Drug-drug-interaction Study to Assess the Effect of Darolutamide on the Pharmacokinetics of Probe Substrates of CYP3A4 and P-gp in Healthy Male Volunteers
Bayer
Phase 1 Completed
NCT01911728 2017-06-26
Drug-drug Interaction Study With MDV3100 and a Cocktail of Substrates
Astellas Pharma Inc
Phase 1 Completed